Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H P Tony

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Zeitschrift Fur Rheumatologie|August 13, 2010
[Tocilizumab. What comes after TNF-blockers in clinical routine?]P Roll, A Rubbert-Roth, H-P Tony
Cardiology|June 9, 2000
Atrial ejection force in systemic autoimmune diseasesR Jahns, J Naito, H P Tony, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1988
Characterization of antigen processing and presentation by resting B lymphocytesE J Gosselin, H P Tony, D C Parker
The Journal of Experimental Medicine|November 1, 1985
Role of membrane immunoglobulin (Ig) crosslinking in membrane Ig-mediated, major histocompatibility-restricted T cell-B cell cooperationH P Tony, N E Phillips, D C Parker
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1988
Characterization of the effector mechanism of help for antigen-presenting and bystander resting B cell growth mediated by Ia-restricted Th2 helper T cell linesB J Whalen, H P Tony, D C Parker
Zeitschrift Fur Rheumatologie|January 28, 2016
[Gynecological cancers in patients with inflammatory rheumatic diseases]M Schmalzing, M Krockenberger, A Honig, et al.
The Journal of Endocrinology|September 1, 1992
Immunological detection of the oestradiol receptor protein in cell lines derived from the lymphatic system and the haematopoietic system: variability of specific hormone binding in vitroF Jakob, H P Tony, D Schneider, et al.
Leukemia|April 1, 1997
First-line therapy of advanced chronic lymphocytic leukemiaM Wilhelm, H P Tony, H Rueckle-Lanz, et al.
European Journal of Biochemistry|October 15, 1994
Design of human interleukin-4 antagonists inhibiting interleukin-4-dependent and interleukin-13-dependent responses in T-cells and B-cells with high efficiencyH P Tony, B J Shen, P Reusch, et al.
Leukemia Research|January 1, 1991
Regulation of IL-4 responsiveness in lymphoma B cellsH P Tony, T Lehrnbecher, H Merz, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Zeitschrift Fur Rheumatologie|August 13, 2010
[Tocilizumab. What comes after TNF-blockers in clinical routine?]P Roll, A Rubbert-Roth, H-P Tony
Cardiology|June 9, 2000
Atrial ejection force in systemic autoimmune diseasesR Jahns, J Naito, H P Tony, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1988
Characterization of antigen processing and presentation by resting B lymphocytesE J Gosselin, H P Tony, D C Parker
The Journal of Experimental Medicine|November 1, 1985
Role of membrane immunoglobulin (Ig) crosslinking in membrane Ig-mediated, major histocompatibility-restricted T cell-B cell cooperationH P Tony, N E Phillips, D C Parker
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1988
Characterization of the effector mechanism of help for antigen-presenting and bystander resting B cell growth mediated by Ia-restricted Th2 helper T cell linesB J Whalen, H P Tony, D C Parker
Zeitschrift Fur Rheumatologie|January 28, 2016
[Gynecological cancers in patients with inflammatory rheumatic diseases]M Schmalzing, M Krockenberger, A Honig, et al.
The Journal of Endocrinology|September 1, 1992
Immunological detection of the oestradiol receptor protein in cell lines derived from the lymphatic system and the haematopoietic system: variability of specific hormone binding in vitroF Jakob, H P Tony, D Schneider, et al.
Leukemia|April 1, 1997
First-line therapy of advanced chronic lymphocytic leukemiaM Wilhelm, H P Tony, H Rueckle-Lanz, et al.
European Journal of Biochemistry|October 15, 1994
Design of human interleukin-4 antagonists inhibiting interleukin-4-dependent and interleukin-13-dependent responses in T-cells and B-cells with high efficiencyH P Tony, B J Shen, P Reusch, et al.
Leukemia Research|January 1, 1991
Regulation of IL-4 responsiveness in lymphoma B cellsH P Tony, T Lehrnbecher, H Merz, et al.
Pageof 9